Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults
Clinical trial NCT03739866 · COMPLETED
Trial details
- NCT number
- NCT03739866
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2019-11-14
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.